Skip to main content
Premium Trial:

Request an Annual Quote

BIT Analytical Acquires C2 Diagnostics

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – BIT Analytical Instruments has acquired French OEM diagnostics instruments firm C2 Diagnostics for an undisclosed sum.

Schwalbach, Germany-based BIT said that the deal will enable it to offer a larger range of services and technologies offered in the areas of clinical chemistry, immunology, and molecular diagnostics.

Monpellier, France-based C2 specializes in developing OEM instruments and has delivered and sold more than 10,000 instruments to small and mid-size diagnostic labs worldwide, said BIT. It added that C2 is currently focused on developing a hematology instrument.

Among BIT's other holdings is Irvine, Calif.-based Source Scientific, which also makes a variety of diagnostics instruments, including those used for molecular diagnostic purposes.

The Scan

Octopus Brain Complexity Linked to MicroRNA Expansions

Investigators saw microRNA gene expansions coinciding with complex brains when they analyzed certain cephalopod transcriptomes, as they report in Science Advances.

Study Tracks Outcomes in Children Born to Zika Virus-Infected Mothers

By following pregnancy outcomes for women with RT-PCR-confirmed Zika virus infections, researchers saw in Lancet Regional Health congenital abnormalities in roughly one-third of live-born children.

Team Presents Benchmark Study of RNA Classification Tools

With more than 135 transcriptomic datasets, researchers tested two dozen coding and non-coding RNA classification tools, establishing a set of potentially misclassified transcripts, as they report in Nucleic Acids Research.

Breast Cancer Risk Related to Pathogenic BRCA1 Mutation May Be Modified by Repeats

Several variable number tandem repeats appear to impact breast cancer risk and age at diagnosis in almost 350 individuals carrying a risky Ashkenazi Jewish BRCA1 founder mutation.